Retrospective Cohort Study
Copyright ©The Author(s) 2020.
World J Clin Cases. Dec 26, 2020; 8(24): 6229-6242
Published online Dec 26, 2020. doi: 10.12998/wjcc.v8.i24.6229
Figure 1
Figure 1 Cumulative disease-free survival rate determined by the date of tumor recurrence, was higher in group A (total number of retrieved lymph nodes, TLN ≥ 12) than in group B (TLN < 12), but there was no difference between the groups in overall survival. DFS: Disease-free survival; OS: Overall survival.